Nestlé Health Science invested in Before Brands, specialists in early childhood food allergy prevention. Gurnet Point Capital, a private investment firm focused on healthcare, invested alongside NHSc in this financing and has led prior financing rounds for Before Brands. Financial terms were not disclosed. "The prevalence of food allergies among children is increasing, however, studies have shown that consistently exposing children at a very early age to a potential food allergen can reduce the development of an allergy to that food by up to 80%. It would be very difficult for parents to achieve this kind of consistent immune-system training to 16 different allergens on their own; SpoonfulOneTM is a convenient and natural solution that fits with the Nestlé Health Science mission of healthier lives through nutrition." Greg Behar, CEO of Nestlé Health Science.